tradingkey.logo
搜索

Glaukos Corp

GKOS
添加自选
137.230USD
+0.870+0.64%
收盘 05/13, 16:00美东报价延迟15分钟
7.89B总市值
亏损市盈率 TTM

Glaukos Corp

137.230
+0.870+0.64%

关于 Glaukos Corp 公司

Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company. The Company is focused on developing and commercializing therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Its commercial solutions and development-stage product candidates include Micro-Invasive Glaucoma Surgery (MIGS) products that primarily involve the insertion of a micro-scale device designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathways for patients suffering from glaucoma; procedural pharmaceuticals based on an intracameral drug delivery technology designed to reduce IOP by delivering therapeutic levels of glaucoma medication from inside the eye over an extended period of time; and bio-activated pharmaceuticals that are intended to strengthen, stabilize, and reshape the cornea for patients impacted by corneal ectatic disorders, such as keratoconus or refractive disorders, among others.

Glaukos Corp简介

公司代码GKOS
公司名称Glaukos Corp
上市日期Jun 25, 2015
CEOBurns (Thomas William)
员工数量995
证券类型Ordinary Share
年结日Jun 25
公司地址1 Glaukos Way
城市ALISO VIEJO
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编92656
电话19493679600
网址https://www.glaukos.com
公司代码GKOS
上市日期Jun 25, 2015
CEOBurns (Thomas William)

Glaukos Corp公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Thomas William Burns
Mr. Thomas William Burns
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.70M
+4.98%
Mr. David F. Hoffmeister
Mr. David F. Hoffmeister
Independent Director
Independent Director
70.09K
-0.25%
Mr. Mark J. Foley
Mr. Mark J. Foley
Lead Independent Director
Lead Independent Director
57.22K
-0.53%
Dr. Tomas Navratil
Dr. Tomas Navratil
Chief Development Officer
Chief Development Officer
50.58K
-4.49%
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
49.69K
+1.65%
Mr. Marc A. Stapley
Mr. Marc A. Stapley
Independent Director
Independent Director
36.72K
-0.51%
Dr. Gilbert H. (Gil) Kliman, M.D.
Dr. Gilbert H. (Gil) Kliman, M.D.
Independent Director
Independent Director
--
--
Mr. Joseph E. Gilliam
Mr. Joseph E. Gilliam
President, Chief Operating Officer
President, Chief Operating Officer
--
--
Dr. Leana S. Wen, M.D.
Dr. Leana S. Wen, M.D.
Independent Director
Independent Director
--
--
Ms. Denice M. Torres, J.D.
Ms. Denice M. Torres, J.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Thomas William Burns
Mr. Thomas William Burns
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.70M
+4.98%
Mr. David F. Hoffmeister
Mr. David F. Hoffmeister
Independent Director
Independent Director
70.09K
-0.25%
Mr. Mark J. Foley
Mr. Mark J. Foley
Lead Independent Director
Lead Independent Director
57.22K
-0.53%
Dr. Tomas Navratil
Dr. Tomas Navratil
Chief Development Officer
Chief Development Officer
50.58K
-4.49%
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
49.69K
+1.65%
Mr. Marc A. Stapley
Mr. Marc A. Stapley
Independent Director
Independent Director
36.72K
-0.51%

收入明细

单位: USD更新时间: 4月6日 周一
单位: USD更新时间: 4月6日 周一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Glaucoma
421.07M
82.98%
Corneal Health
86.37M
17.02%
地区USD
名称
营收
占比
United States
375.04M
73.91%
International
132.40M
26.09%
业务
地区
业务USD
名称
营收
占比
Glaucoma
421.07M
82.98%
Corneal Health
86.37M
17.02%

股东统计

更新时间: 5月11日 周一
更新时间: 5月11日 周一
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.75%
PRIMECAP Management Company
5.74%
Vanguard Portfolio Management, LLC
5.46%
Janus Henderson Investors
5.14%
Vanguard Capital Management, LLC
4.27%
其他
65.64%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.75%
PRIMECAP Management Company
5.74%
Vanguard Portfolio Management, LLC
5.46%
Janus Henderson Investors
5.14%
Vanguard Capital Management, LLC
4.27%
其他
65.64%
股东类型
持股股东
占比
Investment Advisor
50.27%
Investment Advisor/Hedge Fund
31.21%
Hedge Fund
11.62%
Individual Investor
3.59%
Research Firm
1.93%
Pension Fund
1.52%
Sovereign Wealth Fund
0.91%
Bank and Trust
0.79%
Venture Capital
0.50%

机构持股

更新时间: 4月5日 周日
更新时间: 4月5日 周日
报告期
机构数
持股数
持股占比
持股变动
2026Q1
702
59.35M
101.04%
-2.78M
2025Q4
679
58.33M
101.56%
-6.75M
2025Q3
653
61.34M
106.80%
+235.97K
2025Q2
638
61.06M
106.48%
+15.37K
2025Q1
643
60.20M
105.40%
-1.30M
2024Q4
610
59.75M
105.65%
+533.86K
2024Q3
567
57.47M
104.31%
-894.95K
2024Q2
545
56.86M
103.79%
-713.22K
2024Q1
509
54.47M
110.12%
-1.91M
2023Q4
480
53.71M
109.34%
-1.79M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
8.07M
13.9%
+267.99K
+3.43%
Dec 31, 2025
PRIMECAP Management Company
3.38M
5.81%
+1.12M
+49.83%
Dec 31, 2025
Janus Henderson Investors
3.02M
5.2%
+1.95M
+183.40%
Dec 31, 2025
State Street Investment Management (US)
2.12M
3.65%
+18.04K
+0.86%
Dec 31, 2025
Burns (Thomas William)
1.62M
2.78%
+11.71K
+0.73%
Mar 25, 2026
AllianceBernstein L.P.
1.64M
2.83%
-90.03K
-5.19%
Dec 31, 2025
Millennium Management LLC
1.61M
2.77%
+696.29K
+76.23%
Dec 31, 2025
Geode Capital Management, L.L.C.
1.32M
2.27%
+1.56K
+0.12%
Dec 31, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Invesco S&P SmallCap Health Care ETF
3.09%
Alger Weatherbie Enduring Growth ETF
2.07%
State Street SPDR S&P Health Care Equipment ETF
1.79%
ROBO Global Healthcare Technology & Innovation ETF
1.4%
State Street SPDR S&P 600 Small Cap Growth ETF
0.69%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.65%
iShares S&P Small-Cap 600 Growth ETF
0.64%
iShares U.S. Medical Devices ETF
0.6%
OneAscent Enhanced Small and Mid Cap ETF
0.53%
State Street SPDR S&P SmallCap 600 ESG ETF
0.51%
查看更多
Invesco S&P SmallCap Health Care ETF
占比3.09%
Alger Weatherbie Enduring Growth ETF
占比2.07%
State Street SPDR S&P Health Care Equipment ETF
占比1.79%
ROBO Global Healthcare Technology & Innovation ETF
占比1.4%
State Street SPDR S&P 600 Small Cap Growth ETF
占比0.69%
Vanguard S&P Small-Cap 600 Growth Index Fund
占比0.65%
iShares S&P Small-Cap 600 Growth ETF
占比0.64%
iShares U.S. Medical Devices ETF
占比0.6%
OneAscent Enhanced Small and Mid Cap ETF
占比0.53%
State Street SPDR S&P SmallCap 600 ESG ETF
占比0.51%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI